hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Antidiabetic drugs with limited evidence for tumor risk association -Glucosidase inhibitors As an antidiabetic drug, -glucosidase inhibitors primarily act by inhibiting the breakdown of complex carbohydrates in the gastrointestinal tract, thereby slowing their absorption and mitigating postprandial hyperglycemia
Shigeto M, Cha CY, Rorsman P, Kaku K
14 A semaglutide and tirzepatide study in obese individuals yielded similar results, showing a reduction in alcohol intake, binge episodes, average drinks, and AUDIT scores
Clinical trials specifically designed to test semaglutide for alcohol use disorder are now underway at major institutions including the University of North Carolina and several sites across Europe
Leaving the patch on your skin can lead to irritation and contact dermatitis
